HKMPF

Hikma Pharmaceuticals PLC

USD

Set alert

Price alert · HKMPF

All alert types
23.00 USD +0.86 +3.91%
As of Oct 30, 2026
23.00 Day range 23.00
16.34 52-week range 24.32
YTD
+9.84%
1 year
-5.43%
Open
23.00
Prev close
22.14
Mkt cap
4.76B
Vol
7
Avg vol
435
EPS
1.76
P/E
13.07
More statistics
Low
23.00
High
23.00
Earnings
Feb 25, 2027

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for HKMPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.70 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 4

Valuation

P/E 11.3×
FY 2016: 33.3×FY 2017: -4.3×FY 2018: 17.9×FY 2019: 12.9×FY 2020: 18.8×FY 2021: 15.7×FY 2022: 22.5×FY 2023: 26.8×FY 2024: 14.9×FY 2025: 11.3×
FY 2016 5y median 15.7× FY 2025
P/S 1.4×
FY 2016: 2.7×FY 2017: 1.9×FY 2018: 2.4×FY 2019: 2.8×FY 2020: 3.5×FY 2021: 2.6×FY 2022: 1.7×FY 2023: 1.8×FY 2024: 1.7×FY 2025: 1.4×
FY 2016 5y median 1.7× FY 2025
P/B 1.8×
FY 2016: 2.2×FY 2017: 2.4×FY 2018: 3.0×FY 2019: 3.0×FY 2020: 3.8×FY 2021: 2.7×FY 2022: 2.0×FY 2023: 2.3×FY 2024: 2.3×FY 2025: 1.8×
FY 2016 5y median 2.3× FY 2025
P/FCF 27.9×
FY 2016: 30.4×FY 2017: 10.8×FY 2018: 15.7×FY 2019: 17.7×FY 2020: 27.8×FY 2021: 13.4×FY 2022: 10.8×FY 2023: 11.5×FY 2024: 13.4×FY 2025: 27.9×
FY 2016 5y median 13.4× FY 2025
EV/EBITDA 7.4×
FY 2016: 11.7×FY 2017: 7.5×FY 2018: 10.2×FY 2019: 11.1×FY 2020: 11.0×FY 2021: 9.7×FY 2022: 7.6×FY 2023: 7.4×FY 2024: 8.1×FY 2025: 7.4×
FY 2016 5y median 7.6× FY 2025
EV/Sales 1.8×
FY 2016: 3.0×FY 2017: 2.2×FY 2018: 2.6×FY 2019: 2.9×FY 2020: 3.7×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 2.1×FY 2024: 2.1×FY 2025: 1.8×
FY 2016 5y median 2.1× FY 2025
FCF Yield 3.6%
FY 2016: 3.3%FY 2017: 9.3%FY 2018: 6.4%FY 2019: 5.6%FY 2020: 3.6%FY 2021: 7.5%FY 2022: 9.3%FY 2023: 8.7%FY 2024: 7.5%FY 2025: 3.6%
FY 2016 5y median 7.5% FY 2025

Profitability

Gross Margin 42.0%
FY 2016: 48.7%FY 2017: 47.3%FY 2018: 48.5%FY 2019: 49.8%FY 2020: 51.8%FY 2021: 51.0%FY 2022: 50.3%FY 2023: 48.9%FY 2024: 45.3%FY 2025: 42.0%
FY 2016 5y median 48.9% FY 2025
Operating Margin 17.3%
FY 2016: 20.6%FY 2017: 17.4%FY 2018: 20.7%FY 2019: 22.0%FY 2020: 24.7%FY 2021: 22.8%FY 2022: 11.2%FY 2023: 12.8%FY 2024: 19.6%FY 2025: 17.3%
FY 2016 5y median 17.3% FY 2025
Net Margin 12.3%
FY 2016: 7.9%FY 2017: -43.5%FY 2018: 13.6%FY 2019: 22.0%FY 2020: 18.4%FY 2021: 16.5%FY 2022: 7.5%FY 2023: 6.6%FY 2024: 11.5%FY 2025: 12.3%
FY 2016 5y median 11.5% FY 2025
ROE 15.8%
FY 2016: 6.5%FY 2017: -55.7%FY 2018: 16.7%FY 2019: 23.0%FY 2020: 20.2%FY 2021: 17.2%FY 2022: 8.8%FY 2023: 8.6%FY 2024: 15.5%FY 2025: 15.8%
FY 2016 5y median 15.5% FY 2025
ROIC 10.5%
FY 2016: 9.0%FY 2017: 13.4%FY 2018: 16.5%FY 2019: 17.3%FY 2020: 14.7%FY 2021: 13.7%FY 2022: 6.9%FY 2023: 7.2%FY 2024: 12.8%FY 2025: 10.5%
FY 2016 5y median 10.5% FY 2025
ROA 7.2%
FY 2016: 3.6%FY 2017: -24.9%FY 2018: 8.1%FY 2019: 12.4%FY 2020: 10.4%FY 2021: 9.6%FY 2022: 4.2%FY 2023: 4.1%FY 2024: 7.0%FY 2025: 7.2%
FY 2016 5y median 7.0% FY 2025

Growth (YoY)

Revenue 7.1%
FY 2016: 35.4%FY 2017: -0.7%FY 2018: 6.9%FY 2019: 6.6%FY 2020: 6.1%FY 2021: 9.1%FY 2022: -1.4%FY 2023: 14.2%FY 2024: 8.8%FY 2025: 7.1%
FY 2016 FY 2025
Operating Income -5.1%
FY 2016: 2.0%FY 2017: -16.2%FY 2018: 27.4%FY 2019: 13.6%FY 2020: 19.1%FY 2021: 0.5%FY 2022: -51.5%FY 2023: 30.1%FY 2024: 66.8%FY 2025: -5.1%
FY 2016 FY 2025
EPS (diluted) 14.9%
FY 2016: -47.2%FY 2017: -631.8%FY 2018: 133.3%FY 2019: 70.9%FY 2020: -9.5%FY 2021: 0.0%FY 2022: -53.6%FY 2023: 1.2%FY 2024: 89.4%FY 2025: 14.9%
FY 2016 FY 2025
Free Cash Flow -58.5%
FY 2016: -39.8%FY 2017: 96.5%FY 2018: -3.9%FY 2019: 9.3%FY 2020: -17.3%FY 2021: 68.8%FY 2022: -20.5%FY 2023: 12.0%FY 2024: -9.1%FY 2025: -58.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 1.6×FY 2017: 2.0×FY 2018: 1.9×FY 2019: 1.3×FY 2020: 1.9×FY 2021: 2.1×FY 2022: 1.9×FY 2023: 1.6×FY 2024: 1.1×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.1×
FY 2016: 1.1×FY 2017: 1.4×FY 2018: 1.3×FY 2019: 0.9×FY 2020: 1.1×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.6×
FY 2016: 0.4×FY 2017: 0.5×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.6×
FY 2016: 1.4×FY 2017: 1.0×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 0.8×FY 2021: 0.6×FY 2022: 1.5×FY 2023: 1.2×FY 2024: 1.4×FY 2025: 1.6×
FY 2016 5y median 1.4× FY 2025
Interest Coverage 5.4×
FY 2016: 3.9×FY 2017: 5.6×FY 2018: 8.3×FY 2019: 7.3×FY 2020: 10.3×FY 2021: 10.6×FY 2022: 4.1×FY 2023: 4.1×FY 2024: 8.2×FY 2025: 5.4×
FY 2016 5y median 5.4× FY 2025

Dividends

Dividend Yield 4.1%
FY 2016: 1.5%FY 2017: 2.2%FY 2018: 1.7%FY 2019: 1.6%FY 2020: 1.3%FY 2021: 1.8%FY 2022: 3.0%FY 2023: 2.7%FY 2024: 3.3%FY 2025: 4.1%
FY 2016 5y median 3.0% FY 2025
Payout Ratio 46.0%
FY 2016: 49.7%FY 2017: -9.4%FY 2018: 29.8%FY 2019: 20.0%FY 2020: 25.3%FY 2021: 28.5%FY 2022: 66.5%FY 2023: 72.1%FY 2024: 48.7%FY 2025: 46.0%
FY 2016 5y median 48.7% FY 2025

Annual · latest fiscal year ends 2025-12-31